Trends in COVID-19-associated mortality in patients with pulmonary hypertension: a COMPERA analysis

Research output: Contribution to journalLetterContributedpeer-review

Contributors

  • Kai-Helge Schmidt - , University Medical Center Mainz (Author)
  • Katrin Milger - , University Hospital Olomouc (Author)
  • Christine Pausch - , Innovation Center Real World Evidence (Author)
  • Doerte Huscher - , Charité – Universitätsmedizin Berlin (Author)
  • David Pittrow - , Innovation Center Real World Evidence (Author)
  • Ekkehard Grünig - , University Hospital Heidelberg (Author)
  • Gerd Staehler - , SLK-Kliniken Heilbronn GmbH (Author)
  • Henning Gall - , Justus Liebig University Giessen (Author)
  • Oliver Distler - , University Hospital Olomouc (Author)
  • Dirk Skowasch - , University of Bonn Medical Center (Author)
  • Michael Halank - , Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden (Author)
  • Heinrike Wilkens - , University Hospital Carl Gustav Carus Dresden (Author)
  • Matthias Held - , University Hospital of Würzburg (Author)
  • Hans Klose - , University Hospital Hamburg Eppendorf (Author)
  • Marius M Hoeper - , German Center for Lung Research (DZL) (Author)

Abstract

In patients with pulmonary hypertension, the mortality rate associated with COVID-19 has declined sharply with the emergence of the Omicron variants https://bit.ly/42OMsfj

Details

Original languageEnglish
JournalThe European respiratory journal
Volume61
Issue number4
Publication statusPublished - Apr 2023
Peer-reviewedYes

External IDs

PubMedCentral PMC10133582
Scopus 85159242812

Keywords

Keywords

  • Humans, Hypertension, Pulmonary, COVID-19, Risk Assessment, Registries